Measurement of prostate-specific antigen in serum as a screening test for prostate cancer

Volume 324:1156-1161		April 25, 1991		Number 17

Measurement of prostate-specific antigen in serum as a screening test for prostate cancer

WJ Catalona, DS Smith, TL Ratliff, KM Dodds, DE Coplen, JJ Yuan, JA Petros, and GL Andriole

Abstract

Add to Personal Archive

Add to Citation Manager

E-mail When Cited

PubMed Citation

Department of Surgery, Washington University School of Medicine, St. Louis, MO.

This article has been cited by other articles:

Welch, H. G., Albertsen, P. C. (2009). Prostate Cancer Diagnosis and Treatment After the Introduction of Prostate-Specific Antigen Screening: 1986-2005. JNCI J Natl Cancer Inst 101: 1325-1329 [Abstract] [Full Text]
Troyer, D. A., Lucia, M. S., de Bruine, A. P., Mendez-Meza, R., Baldewijns, M. M., Dunscomb, N., Van Engeland, M., McAskill, T., Bierau, K., Louwagie, J., Bigley, J. W. (2009). Prostate Cancer Detected by Methylated Gene Markers in Histopathologically Cancer-Negative Tissues from Men with Subsequent Positive Biopsies. Cancer Epidemiol. Biomarkers Prev. 18: 2717-2722 [Abstract] [Full Text]
Ilic, D., Green, S. (2009). Prostate specific antigen for detecting early prostate cancer. BMJ 339: b3572-b3572 [Full Text]
Nelson, W. G., De Marzo, A. M., Yegnasubramanian, S. (2009). Epigenetic Alterations in Human Prostate Cancers. Endocrinology 150: 3991-4002 [Abstract] [Full Text]
Hillier, S. M., Maresca, K. P., Femia, F. J., Marquis, J. C., Foss, C. A., Nguyen, N., Zimmerman, C. N., Barrett, J. A., Eckelman, W. C., Pomper, M. G., Joyal, J. L., Babich, J. W. (2009). Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer. Cancer Res. 69: 6932-6940 [Abstract] [Full Text]
Zhu, L., Koistinen, H., Landegren, U., Stenman, U.-H. (2009). Proximity Ligation Measurement of the Complex between Prostate Specific Antigen and {alpha}1-Protease Inhibitor. Clin. Chem. 55: 1665-1671 [Abstract] [Full Text]
Arneth, B. M. (2009). Clinical Significance of Measuring Prostate-Specific Antigen. Lab Med 40: 487-491 [Abstract] [Full Text]
Boyle, P., Brawley, O. W. (2009). Prostate Cancer: Current Evidence Weighs Against Population Screening. CA Cancer J Clin 59: 220-224 [Full Text]
Brawley, O. W., Ankerst, D. P., Thompson, I. M. (2009). Screening for Prostate Cancer. CA Cancer J Clin 59: 264-273 [Abstract] [Full Text]
Schroder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L.J., Ciatto, S., Nelen, V., Kwiatkowski, M., Lujan, M., Lilja, H., Zappa, M., Denis, L. J., Recker, F., Berenguer, A., Maattanen, L., Bangma, C. H., Aus, G., Villers, A., Rebillard, X., van der Kwast, T., Blijenberg, B. G., Moss, S. M., de Koning, H. J., Auvinen, A., the ERSPC Investigators, (2009). Screening and Prostate-Cancer Mortality in a Randomized European Study. NEJM 360: 1320-1328 [Abstract] [Full Text]
Dry, S. (2009). Who Owns Diagnostic Tissue Blocks?. Lab Med 40: 69-73 [Full Text]
Vickers, A. J., Lilja, H. (2009). Cutpoints in Clinical Chemistry: Time for Fundamental Reassessment. Clin. Chem. 55: 15-17 [Full Text]
Bellera, C. A., Hanley, J. A., Joseph, L., Albertsen, P. C. (2008). Detecting Trends in Noisy Data Series: Application to Biomarker Series. Am J Epidemiol 167: 1130-1139 [Abstract] [Full Text]
Loeb, S., Catalona, W. J. (2008). What to Do with an Abnormal PSA Test. The Oncologist 13: 299-305 [Abstract] [Full Text]
Laxman, B., Morris, D. S., Yu, J., Siddiqui, J., Cao, J., Mehra, R., Lonigro, R. J., Tsodikov, A., Wei, J. T., Tomlins, S. A., Chinnaiyan, A. M. (2008). A First-Generation Multiplex Biomarker Analysis of Urine for the Early Detection of Prostate Cancer. Cancer Res. 68: 645-649 [Abstract] [Full Text]
Zhang, K., Aruva, M. R., Shanthly, N., Cardi, C. A., Rattan, S., Patel, C., Kim, C., McCue, P. A., Wickstrom, E., Thakur, M. L. (2008). PET Imaging of VPAC1 Expression in Experimental and Spontaneous Prostate Cancer. JNM 49: 112-121 [Abstract] [Full Text]
McLerran, D., Grizzle, W. E., Feng, Z., Thompson, I. M., Bigbee, W. L., Cazares, L. H., Chan, D. W., Dahlgren, J., Diaz, J., Kagan, J., Lin, D. W., Malik, G., Oelschlager, D., Partin, A., Randolph, T. W., Sokoll, L., Srivastava, S., Srivastava, S., Thornquist, M., Troyer, D., Wright, G. L., Zhang, Z., Zhu, L., Semmes, O. J. (2008). SELDI-TOF MS Whole Serum Proteomic Profiling with IMAC Surface Does Not Reliably Detect Prostate Cancer. Clin. Chem. 54: 53-60 [Abstract] [Full Text]
Jewett, M. A.S., Klotz, L. H., for the University of Toronto Uro-Oncology Program, (2007). Advances in the medical management of benign prostatic hyperplasia. CMAJ 176: 1850-1851 [Full Text]
Thompson, I. M., Ankerst, D. P. (2007). Prostate-specific antigen in the early detection of prostate cancer. CMAJ 176: 1853-1858 [Abstract] [Full Text]
Safarinejad, M. R. (2006). Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Iran. Ann Oncol 17: 1166-1171 [Abstract] [Full Text]
Taylor, L. S., Rubens, D. J., Porter, B. C., Wu, Z., Baggs, R. B., di Sant'Agnese, P. A., Nadasdy, G., Pasternack, D., Messing, E. M., Nigwekar, P., Parker, K. J. (2005). Prostate Cancer: Three-dimensional Sonoelastography for in Vitro Detection. Radiology 237: 981-985 [Abstract] [Full Text]
Talcott, J. A. (2005). Rebalancing Ratios and Improving Impressions: Later Thoughts From the Prostate Cancer Prevention Trial Investigators. JCO 23: 7388-7390 [Full Text]
Wang, X., Yu, J., Sreekumar, A., Varambally, S., Shen, R., Giacherio, D., Mehra, R., Montie, J. E., Pienta, K. J., Sanda, M. G., Kantoff, P. W., Rubin, M. A., Wei, J. T., Ghosh, D., Chinnaiyan, A. M. (2005). Autoantibody Signatures in Prostate Cancer. NEJM 353: 1224-1235 [Abstract] [Full Text]
Bernstein, J. L., Godbold, J. H., Raptis, G., Watson, M. A., Levinson, B., Aaronson, S. A., Fleming, T. P. (2005). Identification of Mammaglobin as a Novel Serum Marker for Breast Cancer. Clin. Cancer Res. 11: 6528-6535 [Abstract] [Full Text]
Welch, H. G., Schwartz, L. M., Woloshin, S. (2005). Prostate-Specific Antigen Levels in the United States: Implications of Various Definitions for Abnormal. JNCI J Natl Cancer Inst 97: 1132-1137 [Abstract] [Full Text]
Paul, B., Dhir, R., Landsittel, D., Hitchens, M. R., Getzenberg, R. H. (2005). Detection of Prostate Cancer with a Blood-Based Assay for Early Prostate Cancer Antigen. Cancer Res. 65: 4097-4100 [Abstract] [Full Text]
Bradley, S. V., Oravecz-Wilson, K. I., Bougeard, G., Mizukami, I., Li, L., Munaco, A. J., Sreekumar, A., Corradetti, M. N., Chinnaiyan, A. M., Sanda, M. G., Ross, T. S. (2005). Serum Antibodies to Huntingtin Interacting Protein-1: A New Blood Test for Prostate Cancer. Cancer Res. 65: 4126-4133 [Abstract] [Full Text]
Freedland, S. J., Isaacs, W. B., Mangold, L. A., Yiu, S. K., Grubb, K. A., Partin, A. W., Epstein, J. I., Walsh, P. C., Platz, E. A. (2005). Stronger Association between Obesity and Biochemical Progression after Radical Prostatectomy among Men Treated in the Last 10 Years. Clin. Cancer Res. 11: 2883-2888 [Abstract] [Full Text]
Grossman, H. B., Messing, E., Soloway, M., Tomera, K., Katz, G., Berger, Y., Shen, Y. (2005). Detection of Bladder Cancer Using a Point-of-Care Proteomic Assay. JAMA 293: 810-816 [Abstract] [Full Text]
Beyersdorff, D., Winkel, A., Hamm, B., Lenk, S., Loening, S. A., Taupitz, M. (2005). MR Imaging-guided Prostate Biopsy with a Closed MR Unit at 1.5 T: Initial Results. Radiology 234: 576-581 [Abstract] [Full Text]
(2004). Management of localised prostate cancer. DTB 42: 81-85 [Abstract] [Full Text]
Johansson, J.-E., Andren, O., Andersson, S.-O., Dickman, P. W., Holmberg, L., Magnuson, A., Adami, H.-O. (2004). Natural History of Early, Localized Prostate Cancer. JAMA 291: 2713-2719 [Abstract] [Full Text]
Kaufman, H. L., Wang, W., Manola, J., DiPaola, R. S., Ko, Y.-J., Sweeney, C., Whiteside, T. L., Schlom, J., Wilding, G., Weiner, L. M. (2004). Phase II Randomized Study of Vaccine Treatment of Advanced Prostate Cancer (E7897): A Trial of the Eastern Cooperative Oncology Group. JCO 22: 2122-2132 [Abstract] [Full Text]
Mikolajczyk, S. D., Catalona, W. J., Evans, C. L., Linton, H. J., Millar, L. S., Marker, K. M., Katir, D., Amirkhan, A., Rittenhouse, H. G. (2004). Proenzyme Forms of Prostate-Specific Antigen in Serum Improve the Detection of Prostate Cancer. Clin. Chem. 50: 1017-1025 [Abstract] [Full Text]
Thompson, I. M., Pauler, D. K., Goodman, P. J., Tangen, C. M., Lucia, M. S., Parnes, H. L., Minasian, L. M., Ford, L. G., Lippman, S. M., Crawford, E. D., Crowley, J. J., Coltman, C. A. Jr. (2004). Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level <=4.0 ng per Milliliter. NEJM 350: 2239-2246 [Abstract] [Full Text]
Taylor, P. R., Parnes, H. L., Lippman, S. M. (2004). Science Peels the Onion of Selenium Effects on Prostate Carcinogenesis. JNCI J Natl Cancer Inst 96: 645-647 [Full Text]
Yegnasubramanian, S., Kowalski, J., Gonzalgo, M. L., Zahurak, M., Piantadosi, S., Walsh, P. C., Bova, G. S., De Marzo, A. M., Isaacs, W. B., Nelson, W. G. (2004). Hypermethylation of CpG Islands in Primary and Metastatic Human Prostate Cancer. Cancer Res. 64: 1975-1986 [Abstract] [Full Text]
Law, M. (2004). Screening without evidence of efficacy. BMJ 328: 301-302 [Full Text]
Mohler, J. L., Gregory, C. W., Ford, O. H. III, Kim, D., Weaver, C. M., Petrusz, P., Wilson, E. M., French, F. S. (2004). The Androgen Axis in Recurrent Prostate Cancer. Clin. Cancer Res. 10: 440-448 [Abstract] [Full Text]
Thompson, I., Leach, R. J., Pollock, B. H., Naylor, S. L. (2003). Prostate Cancer and Prostate-Specific Antigen: The More We Know, the Less We Understand. JNCI J Natl Cancer Inst 95: 1027-1028 [Full Text]
Aksoy, Y., Oral, A., Aksoy, H., Demirel, A., Akcay, F. (2003). PSA Density and PSA Transition Zone Density in the Diagnosis of Prostate Cancer in PSA Gray Zone Cases. Annals of Clinical & Laboratory Science 33: 320-323 [Abstract] [Full Text]
Wesseling, S., Stephan, C., Semjonow, A., Lein, M., Brux, B., Sinha, P., Loening, S. A., Jung, K. (2003). Determination of Non-{alpha}1-Antichymotrypsin-complexed Prostate-specific Antigen as an Indirect Measurement of Free Prostate-specific Antigen: Analytical Performance and Diagnostic Accuracy. Clin. Chem. 49: 887-894 [Abstract] [Full Text]
Khan, M. A., Partin, A. W. (2003). Management of High-Risk Populations with Locally Advanced Prostate Cancer. The Oncologist 8: 259-269 [Abstract] [Full Text]
Eastham, J. A., Riedel, E., Scardino, P. T., Shike, M., Fleisher, M., Schatzkin, A., Lanza, E., Latkany, L., Begg, C. B. (2003). Variation of Serum Prostate-Specific Antigen Levels: An Evaluation of Year-to-Year Fluctuations. JAMA 289: 2695-2700 [Abstract] [Full Text]
Oottamasathien, S., Crawford, E. D. (2003). Should Routine Screening for Prostate-Specific Antigen Be Recommended?. Arch Intern Med 163: 661-663 [Full Text]
Linton, H. J., Marks, L. S., Millar, L. S., Knott, C. L., Rittenhouse, H. G., Mikolajczyk, S. D. (2003). Benign Prostate-specific Antigen (BPSA) in Serum Is Increased in Benign Prostate Disease. Clin. Chem. 49: 253-259 [Abstract] [Full Text]
Balk, S. P., Ko, Y.-J., Bubley, G. J. (2003). Biology of Prostate-Specific Antigen. JCO 21: 383-391 [Abstract] [Full Text]
Ferrando, A. A., Sheffield-Moore, M., Paddon-Jones, D., Wolfe, R. R., Urban, R. J. (2003). Differential Anabolic Effects of Testosterone and Amino Acid Feeding in Older Men. J. Clin. Endocrinol. Metab. 88: 358-362 [Abstract] [Full Text]
Zhu, L., Leinonen, J., Zhang, W.-M., Finne, P., Stenman, U.-H. (2003). Dual-Label Immunoassay for Simultaneous Measurement of Prostate-specific Antigen (PSA)-{alpha}1-Antichymotrypsin Complex Together with Free or Total PSA. Clin. Chem. 49: 97-103 [Abstract] [Full Text]
Isono, T., Tanaka, T., Kageyama, S., Yoshiki, T. (2002). Structural Diversity of Cancer-related and Non-Cancer-related Prostate-specific Antigen. Clin. Chem. 48: 2187-2194 [Abstract] [Full Text]
Leinonen, J., Wu, P., Stenman, U.-H. (2002). Epitope Mapping of Antibodies against Prostate-specific Antigen with Use of Peptide Libraries. Clin. Chem. 48: 2208-2216 [Abstract] [Full Text]
Jain, S, Bhojwani, A G, Mellon, J K (2002). Improving the utility of prostate specific antigen (PSA) in the diagnosis of prostate cancer: the use of PSA derivatives and novel markers. Postgrad. Med. J. 78: 646-650 [Abstract] [Full Text]
Beyersdorff, D., Taupitz, M., Winkelmann, B., Fischer, T., Lenk, S., Loening, S. A., Hamm, B. (2002). Patients with a History of Elevated Prostate-Specific Antigen Levels and Negative Transrectal US-guided Quadrant or Sextant Biopsy Results: Value of MR Imaging. Radiology 224: 701-706 [Abstract] [Full Text]
Bunker, C. H., Patrick, A. L., Konety, B. R., Dhir, R., Brufsky, A. M., Vivas, C. A., Becich, M. J., Trump, D. L., Kuller, L. H. (2002). High Prevalence of Screening-detected Prostate Cancer among Afro-Caribbeans: The Tobago Prostate Cancer Survey. Cancer Epidemiol. Biomarkers Prev. 11: 726-729 [Abstract] [Full Text]
Rawstron, A. C., Green, M. J., Kuzmicki, A., Kennedy, B., Fenton, J. A. L., Evans, P. A. S., O'Connor, S. J. M., Richards, S. J., Morgan, G. J., Jack, A. S., Hillmen, P. (2002). Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood 100: 635-639 [Abstract] [Full Text]
Djavan, B., Remzi, M., Zlotta, A., Seitz, C., Snow, P., Marberger, M. (2002). Novel Artificial Neural Network for Early Detection of Prostate Cancer. JCO 20: 921-929 [Abstract] [Full Text]
Serdar, M. A., Oguz, O., Olgun, A., Seckin, B., Ilgan, S., Hasimi, A., Salih, M., Peker, F., Kutluay, T. (2002). Diagnostic Approach to Prostate Cancer using Total Prostate Specific Antigen-Based Parameters Together. Annals of Clinical & Laboratory Science 32: 22-30 [Abstract] [Full Text]
Shenk, J. L., Fisher, C. J., Chen, S.-Y., Zhou, X.-F., Tillman, K., Shemshedini, L. (2001). p53 Represses Androgen-induced Transactivation of Prostate-specific Antigen by Disrupting hAR Amino- to Carboxyl-terminal Interaction. J. Biol. Chem. 276: 38472-38479 [Abstract] [Full Text]
Mikolajczyk, S. D., Marker, K. M., Millar, L. S., Kumar, A., Saedi, M. S., Payne, J. K., Evans, C. L., Gasior, C. L., Linton, H. J., Carpenter, P., Rittenhouse, H. G. (2001). A Truncated Precursor Form of Prostate-specific Antigen Is a More Specific Serum Marker of Prostate Cancer. Cancer Res. 61: 6958-6963 [Abstract] [Full Text]
Yousef, G. M., Diamandis, E. P. (2001). The New Human Tissue Kallikrein Gene Family: Structure, Function, and Association to Disease. Endocr. Rev. 22: 184-204 [Abstract] [Full Text]
Ganz, P. A., Litwin, M. S. (2001). Prostate Cancer: The Price of Early Detection. JCO 19: 1587-1588 [Full Text]
Thornbury, J. R., Ornstein, D. K., Choyke, P. L., Langlotz, C. P., Weinreb, J. C. (2001). Prostate Cancer: What Is the Future Role for Imaging?. Am. J. Roentgenol. 176: 17-22 [Full Text]
Stephan, C., Jung, K., Lein, M., Sinha, P., Schnorr, D., Loening, S. A. (2000). Molecular Forms of Prostate-specific Antigen and Human Kallikrein 2 as Promising Tools for Early Diagnosis of Prostate Cancer. Cancer Epidemiol. Biomarkers Prev. 9: 1133-1147 [Abstract] [Full Text]
Finne, P., Auvinen, A., Koistinen, H., Zhang, W.-M., Määttänen, L., Rannikko, S., Tammela, T., Seppälä, M., Hakama, M., Stenman, U.-H. (2000). Insulin-Like Growth Factor I Is Not a Useful Marker of Prostate Cancer in Men with Elevated Levels of Prostate-Specific Antigen. J. Clin. Endocrinol. Metab. 85: 2744-2747 [Abstract] [Full Text]
Uchida, K., Takeshima, H., Akaza, H., Ono, Y. (2000). Screening for Prostate Cancer Using Prostate-specific Antigen Alone as a First-line Checkup Parameter: Results of the Health Checkup System. Jpn J Clin Oncol 30: 95-100 [Abstract] [Full Text]
Mikolajczyk, S. D., Millar, L. S., Wang, T. J., Rittenhouse, H. G., Marks, L. S., Song, W., Wheeler, T. M., Slawin, K. M. (2000). A Precursor Form of Prostate-specific Antigen Is More Highly Elevated in Prostate Cancer Compared with Benign Transition Zone Prostate Tissue. Cancer Res. 60: 756-759 [Abstract] [Full Text]
Prakash, S., Robbins, P. W. (2000). Glycotyping of prostate specific antigen. Glycobiology 10: 173-176 [Abstract] [Full Text]
Negri, C., Tosi, F., Dorizzi, R., Fortunato, A., Spiazzi, G. G., Muggeo, M., Castello, R., Moghetti, P. (2000). Antiandrogen Drugs Lower Serum Prostate-Specific Antigen (PSA) Levels in Hirsute Subjects: Evidence That Serum PSA Is a Marker of Androgen Action in Women. J. Clin. Endocrinol. Metab. 85: 81-84 [Abstract] [Full Text]
Tanaka, T., Isono, T., Yoshiki, T., Yuasa, T., Okada, Y. (2000). A Novel Form of Prostate-specific Antigen Transcript Produced by Alternative Splicing. Cancer Res. 60: 56-59 [Abstract] [Full Text]
Jung, K., Elgeti, U., Lein, M., Brux, B., Sinha, P., Rudolph, B., Hauptmann, S., Schnorr, D., Loening, S. A. (2000). Ratio of Free or Complexed Prostate-specific Antigen (PSA) to Total PSA: Which Ratio Improves Differentiation between Benign Prostatic Hyperplasia and Prostate Cancer?. Clin. Chem. 46: 55-62 [Abstract] [Full Text]
Stege, R., Grande, M., Carlström, K., Tribukait, B., Pousette, A. (2000). Prognostic Significance of Tissue Prostate-specific Antigen in Endocrine-treated Prostate Carcinomas. Clin. Cancer Res. 6: 160-165 [Abstract] [Full Text]
Hoogendam, A., Buntinx, F., de Vet, H. C. (1999). The diagnostic value of digital rectal examination in primary care screening for prostate cancer: a meta-analysis. Fam Pract 16: 621-626 [Abstract] [Full Text]
Sutkowski, D. M., Goode, R. L., Baniel, J., Teater, C., Cohen, P., McNulty, A. M., Hsiung, H. M., Becker, G. W., Neubauer, B. L. (1999). Growth Regulation of Prostatic Stromal Cells by Prostate-Specific Antigen. JNCI J Natl Cancer Inst 91: 1663-1669 [Abstract] [Full Text]
Jhaveri, F. M., Klein, E. A., Kupelian, P. A., Zippe, C., Levin, H. S. (1999). Declining Rates of Extracapsular Extension After Radical Prostatectomy: Evidence for Continued Stage Migration. JCO 17: 3167-3172 [Abstract] [Full Text]
Virtanen, A., Gomari, M., Kranse, R. (1999). Estimation of Prostate Cancer Probability by Logistic Regression: Free and Total Prostate-specific Antigen, Digital Rectal Examination, and Heredity Are Significant Variables. Clin. Chem. 45: 987-994 [Abstract] [Full Text]
Stenman, U.-H. (1999). New Ultrasensitive Assays Facilitate Studies on the Role of Human Glandular Kallikrein (hK2) as a Marker for Prostatic Disease. Clin. Chem. 45: 753-754 [Full Text]
Zhang, W.-M., Finne, P., Leinonen, J., Vesalainen, S., Nordling, S., Stenman, U.-H. (1999). Measurement of the Complex between Prostate-specific Antigen and {alpha}1-Protease Inhibitor in Serum. Clin. Chem. 45: 814-821 [Abstract] [Full Text]
Scher, H. I. (1999). Management of Prostate Cancer After Prostatectomy: Treating the Patient, Not the PSA. JAMA 281: 1642-1645 [Full Text]
Michel, S., Deleage, G., Charrier, J.-P., Passagot, J., Battail-Poirot, N., Sibai, G., Jolivet, M., Jolivet-Reynaud, C. (1999). Anti-Free Prostate-specific Antigen Monoclonal Antibody Epitopes Defined by Mimotopes and Molecular Modeling. Clin. Chem. 45: 638-650 [Abstract] [Full Text]
Nelson, P. S., Gan, L., Ferguson, C., Moss, P., Gelinas, R., Hood, L., Wang, K. (1999). Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression. Proc. Natl. Acad. Sci. USA 96: 3114-3119 [Abstract] [Full Text]
Mohan, R. R., Challa, A., Gupta, S., Bostwick, D. G., Ahmad, N., Agarwal, R., Marengo, S. R., Amini, S. B., Paras, F., MacLennan, G. T., Resnick, M. I., Mukhtar, H. (1999). Overexpression of Ornithine Decarboxylase in Prostate Cancer and Prostatic Fluid in Humans. Clin. Cancer Res. 5: 143-147 [Abstract] [Full Text]
Saedi, M. S., Hill, T. M., Kuus-Reichel, K., Kumar, A., Payne, J., Mikolajczyk, S. D., Wolfert, R. L., Rittenhouse, H. G. (1998). The precursor form of the human kallikrein 2, a kallikrein homologous to prostate-specific antigen, is present in human sera and is increased in prostate cancer and benign prostatic hyperplasia. Clin. Chem. 44: 2115-2119 [Abstract] [Full Text]
Stern, S., Altkorn, D., Levinson, W. (1998). Detection of Prostate and Colon Cancer. JAMA 280: 117-118 [Full Text]
Allard, W. J., Zhou, Z., Yeung, K. K. (1998). Novel immunoassay for the measurement of complexed prostate-specific antigen in serum. Clin. Chem. 44: 1216-1223 [Abstract] [Full Text]
Takayama, T. K., Fujikawa, K., Davie, E. W. (1997). Characterization of the Precursor of Prostate-specific Antigen. ACTIVATION BY TRYPSIN AND BY HUMAN GLANDULAR KALLIKREIN. J. Biol. Chem. 272: 21582-21588 [Abstract] [Full Text]
Cleutjens, K. B. J .M., van der Korput, H. A. G. M., Ehren-van Eekelen, C. C., Sikes, R. A., Fasciana, C., Chung, L. W., Trapman, J. (1997). A 6-kb Promoter Fragment Mimics in Transgenic Mice the Prostate-Specific and Androgen-Regulated Expression of the Endogenous Prostate-Specific Antigen Gene in Humans. Mol. Endocrinol. 11: 1256-1265 [Abstract] [Full Text]
Catalona, W. J., Smith, D. S., Ornstein, D. K. (1997). Prostate Cancer Detection in Men With Serum PSA Concentrations of 2.6 to 4.0 ng/mL and Benign Prostate Examination: Enhancement of Specificity With Free PSA Measurements. JAMA 277: 1452-1455 [Abstract]
Cleutjens, K. B. J. M., van der Korput, H. A. G. M., van Eekelen, C. C. E. M., van Rooij, H. C. J., Faber, P. W., Trapman, J. (1997). An Androgen Response Element in a Far Upstream Enhancer Region Is Essential for High, Androgen-Regulated Activity of the Prostate-Specific Antigen Promoter. Mol. Endocrinol. 11: 148-161 [Abstract] [Full Text]
Collins, M. M., Barry, M. J. (1996). Controversies in Prostate Cancer Screening: Analogies to the Early Lung Cancer Screening Debate. JAMA 276: 1976-1979 [Abstract]
Morgentaler, A., Bruning, C. O. III, DeWolf, W. C. (1996). Occult Prostate Cancer in Men With Low Serum Testosterone Levels. JAMA 276: 1904-1906 [Abstract]
Smith, D. S., Catalona, W. J., Herschman, J. D. (1996). Longitudinal Screening for Prostate Cancer With Prostate-Specific Antigen. JAMA 276: 1309-1315 [Abstract]
Cleutjens, K. B. J. M., van Eekelen, C. C. E. M., van der Korput, H. A. G. M., Brinkmann, A. O., Trapman, J. (1996). Two Androgen Response Regions Cooperate in Steroid Hormone Regulated Activity of the Prostate-specific Antigen Promoter. J. Biol. Chem. 271: 6379-6388 [Abstract] [Full Text]

Comments and questions? Please contact us.